Creve Coeur, MO -- (SBWIRE) -- 03/07/2016 -- The cost of new drugs and medical devices is skyrocketing making them unaffordable to many in dire need. Bio-Pharma companies are required to conduct extensive clinical trials; to get their new drugs approved for launch by FDA and other global regulatory agencies. The high cost and risk of conducting clinical trials, are a major driver in making new drugs unaffordable.
Read the full press release at http://www.sbwire.com/press-releases/new-life-saving-drugs-may-finally-become-affordable-as-clinical-data-inc-launches-a-disruptive-clinical-technology-platform-670900.htm